For complete study information, view the study on clinicaltrials.gov
Patients with Cystic Fibrosis ≥ 18 years of age planned to initiate intravenous (IV) antibiotics for a pulmonary exacerbation
Patients who have been treated with IV antibiotics within 6 weeks prior to Visit 1
CFFT Therapeutics Development Network Coordinating Center (TDNCC)
For more information, contact: Brenda Bourne 330-543-3510 or Michelle Powers 330-543-3089
Director, Lewis H Walker CF Center; Pediatric Pulmonologist; Pediatric Sleep Medicine
Lewis H. Walker, MD, Cystic Fibrosis CenterRobert T. Stone, MD, Respiratory CenterPediatric Sleep Medicine